Xuejian Li,
Zhenkun Huang,
Zhihuan Liao,
Aijie Liu* and
Shuaidong Huo*
Fujian Provincial Key Laboratory of Innovative Drug Target Research, School of Pharmaceutical Sciences, Xiamen University, Xiamen 361102, China. E-mail: huosd@xmu.edu.cn; aijieliu@xmu.edu.cn
First published on 28th May 2025
Correction for ‘Transformable nanodrugs for overcoming the biological barriers in the tumor environment during drug delivery’ by Xuejian Li et al., Nanoscale, 2023, 15, 8532–8547, https://doi.org/10.1039/D2NR06621A.
The corrected Acknowledgements section should read as follows.
This work was supported by the National Natural Science Foundation of China (NSFC) (grant no. 82001959), Natural Science Foundation of Xiamen, China (No. 3502Z20227004) and the Fundamental Research Funds for the Central Universities (20720210102). A. L. and S. H. are grateful for financial support from the Nanqiang Outstanding Young Talents Program from Xiamen University.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
This journal is © The Royal Society of Chemistry 2025 |